GO
Loading...

Aegerion CEO on Promise of Biopharma

Wednesday, 23 Jan 2013 | 6:43 AM ET

Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's portfolio that treats patients with severe cholesterol disorder.